Helvenstein, M., Hambye, S., & Blankert, B. (04 April 2017). Hepatocyte-based flow analytical bioreactor for online xenobiotics metabolism bioprediction. Nanobiomedicine, 4, 1-11. ![]() |
![]() | Helvenstein, M., Stanicki, D., Laurent, S., & Blankert, B. (2015). Interaction between iron oxide nanoparticles and HepaRG cells: a preliminary In vitro evaluation. Journal of Nanomaterials. doi:10.1155/2015/463841 ![]() |
Helvenstein, M. (2015). 'Bioréacteur à base de cellules magnétiquement marquées pour l'étude de la biotransformation de substances d'intérêt pharmaceutique : développement et évaluation.'. Unpublished doctoral thesis, Université de Mons. Jury: Blankert, B. (Promotor), Duez, P., Colet, J.-M., Kauffmann, J.-M., Gossuin, Y., & Daali, Y. |
Fouad, M., Helvenstein, M., & Blankert, B. (2015). Ultra High Performance Liquid Chromatography Method for the Determination of Two Recently FDA Approved TKIs in Human Plasma Using Diode Array Detection. Journal of Analytical Methods in Chemistry. doi:10.1155/2015/215128 ![]() |
Helvenstein, M., Hambye, S., & Blankert, B. (15 March 2015). Determination of three tyrosine kinase inhibitors and one active metabolite by a validated UPLC-DAD method in human plasma. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Hambye, S., Helvenstein, M., Vanden Eynde, J. J., & Blankert, B. (15 March 2015). First UPLC-Fluo/PDA quantification method of pentamidine and a new promising analogue in biological fluids. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Helvenstein, M., Fouad, M., & Blankert, B. (15 March 2015). Development and validation of UPLC-DAD method for the determination of two recently FDA approved TKIs in human plasma for therapeutic drug monitoring. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Romoaldo, G., Helvenstein, M., Hambye, S., & Blankert, B. (15 March 2015). Identification et quantification de biomarqueurs d'états émotionnels. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Helvenstein, M., Hambye, S., & Blankert, B. (07 July 2014). Determination of three tyrosine kinase inhibitors and one active metabolite by an identical and validated ultra-performance liquid chromatography-DAD method in human plasma. Current Pharmaceutical Analysis, 10, 161-168. ![]() |
Hambye, S., Helvenstein, M., Vanden Eynde, J.-J., & Blankert, B. (23 June 2014). First UPLC-Fluo/PDA quantification method of Pentamidine and a new promising analogue in biological fluids. Poster session presented at Drug Analysis, Liège, Belgium. |
Helvenstein, M., Stanicki, D., & Blankert, B. (22 June 2014). In vitro evaluation of the interaction of iron oxide nanoparticles with the HepaRG cells. Poster session presented at Drug Analysis, Liège, Belgium. |
Nachtergael, A., Coulembier, O., Dubois, P., Helvenstein, M., Duez, P., Blankert, B., & Mespouille, L. (22 June 2014). Organocatalysis paradigm revised: are metal-free catalysts really harmless? Poster session presented at Drug Analysis, Liège, Belgium. |
Helvenstein, M., Hambye, S., & Blankert, B. (22 June 2014). Determination of three tyrosine kinase inhibitors and one active metabolite by a validated UPLC-DAD method in human plasma. Poster session presented at Drug Analysis, Liège, Belgium. |
![]() | Helvenstein, M., Hambye, S., & Blankert, B. (13 February 2014). UPLC-DAD method validation by accuracy profiles approach of tyrosine kinase inhibitors in human plasma. Poster session presented at 6ème Journée Scientifique du Pôle hainuyer, Mons, Belgium. |
Hambye, S., Helvenstein, M., Verdy, L., Kahvecioglu, Z. C., Conotte, R., Vanden Eynde, J.-J., Colet, J.-M., & Blankert, B. (10 February 2014). Ultra High Performance Liquid Chromatography method for the determination of Pentamidine and analog in rat biological fluids. Journal of Pharmaceutical and Biomedical Analysis, 95, 54-60. ![]() |
Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (29 October 2013). A similar UPLC-UV method for three tyrosine kinase inhibitors determination in human plasma. Paper presented at 17th Forum of Pharmaceutical Sciences, Spa, Belgium. |
![]() | Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (30 June 2013). Ultra-performance liquid chromatography method for the determination of tyrosine kinase inhibitors in human plasma. Poster session presented at 24th International Symposium on Pharmaceutical and Biomedical Analysis, Bologne, Italy. |
Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (24 May 2013). Tyrosine kinase inhibitors quantification by UPLC-UV in human plasma. Poster session presented at Health Institute Day, Mons, Umons, Belgium. |
![]() | Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (12 March 2013). Tyrosine kinase inhibitors quantification in human plasma. Poster session presented at 7ième Matinée des Chercheurs, Mons, Belgium. |
Hambye, S., Ansseau, E., Helvenstein, M., Carminati, A., Vanden Eynde, J.-J., Belayew, A., & Blankert, B. (12 March 2013). Analytical developments and biological evaluation (in Steinert desease) of Pentamidine and new analogs. Poster session presented at 7ième Matinée des Chercheurs, Mons, Belgium. |
Lenaerts, C., Helvenstein, M., & Blankert, B. (29 January 2013). Marinobufagenin and its applications in the diagnosis of preeclampsia. Poster session presented at Journée scientifique des doctorants en Sciences Biomédicales et Pharmaceutiques: 'New tools and strategies in identification of pathology-related biomarkers', UMONS, Belgium. |